We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
-1.25%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$59.2B
AUM Growth
-$8.49B
(-13%)
Cap. Flow
-$7.82B
Cap. Flow
% of AUM
-13.2%
Top 10 Holdings %
Top 10 Hldgs %
53.15%
Holding
195
New
15
Increased
41
Reduced
72
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$718M |
| 2 |
Peloton Interactive
PTON
|
+$359M |
| 3 |
Gartner
IT
|
+$355M |
| 4 |
Synopsys
SNPS
|
+$195M |
| 5 |
KE Holdings
BEKE
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinterest
PINS
|
+$357M |
| 2 |
Apple
AAPL
|
+$332M |
| 3 |
Bilibili
BILI
|
+$98.6M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$52.2M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$50.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Consumer Discretionary | 9.35% |
| 3 | Communication Services | 4.36% |
| 4 | Financials | 3.87% |
| 5 | Healthcare | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Keros Therapeutics
KROS
$221M
| $27.7M | 0.05% |
701,433
-2,006
| -0.3% | -$71.4K |
|
|
KLRS
127
Kalaris Therapeutics
KLRS
$96.8M
| $27.4M | 0.05% |
47,544
| – | – |
|
|
MORF
128
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $22.2M | 0.04% |
391,452
-548
| -0.1% | -$33.2K |
|
129
ServiceNow
NOW
$129B
| $22M | 0.04% |
176,855
| – | – |
|
|
RNAM
130
DELISTED
Avidity Biosciences
RNAM
| $21.5M | 0.04% |
871,426
| – | – |
|
131
Oric Pharmaceuticals
ORIC
$1.4B
| $20.8M | 0.04% |
996,989
| – | – |
|
132
Schrodinger
SDGR
$1.36B
| $19.1M | 0.03% |
349,206
-794
| -0.2% | -$50.8K |
|
133
Take-Two Interactive
TTWO
$46.1B
| $17.9M | 0.03% |
115,916
+100,000
| +628% | +$16.2M |
|
134
GeneDx Holdings
WGS
$2.3B
| $17.5M | 0.03% |
69,955
| – | – |
|
|
MRSN
135
DELISTED
Mersana Therapeutics
MRSN
| $17M | 0.03% |
71,994
-257
| -0.4% | -$75.1K |
|
136
4D Molecular Therapeutics
FDMT
$562M
| $16.2M | 0.03% |
602,225
+99,299
| +20% | +$2.83M |
|
137
Dolby
DLB
$5.79B
| $15.4M | 0.03% |
175,000
+25,000
| +17% | +$2.42M |
|
|
DCPH
138
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $13.5M | 0.02% |
396,977
-270,200
| -40% | -$8.62M |
|
|
MIMO
139
DELISTED
Airspan Networks Holdings Inc
MIMO
| $13.4M | 0.02% |
+2,000,000
| New | +$18M |
|
140
Stem
STEM
$52.7M
| $13.1M | 0.02% |
27,500
| – | – |
|
141
Recursion Pharmaceuticals
RXRX
$1.73B
| $12.6M | 0.02% |
548,455
-1,545
| -0.3% | -$43.8K |
|
142
Karyopharm Therapeutics
KPTI
$48M
| $11.4M | 0.02% |
130,773
-46,772
| -26% | -$4.86M |
|
|
APLT
143
DELISTED
Applied Therapeutics
APLT
| $10.6M | 0.02% |
639,458
-401,876
| -39% | -$6.94M |
|
144
VTEX
VTEX
$713M
| $10.3M | 0.02% |
+498,621
| New | +$12.4M |
|
145
Xometry
XMTR
$5.34B
| $10.1M | 0.02% |
175,000
+40,000
| +30% | +$2.77M |
|
|
YSG
146
Yatsen Holding
YSG
$319M
| $10.1M | 0.02% |
527,938
-1,596
| -0.3% | -$48.7K |
|
147
Riskified
RSKD
$716M
| $9.09M | 0.02% |
+398,385
| New | +$11.2M |
|
148
Datadog
DDOG
$84B
| $8.33M | 0.01% |
58,915
| – | – |
|
149
Sarepta Therapeutics
SRPT
$1.77B
| $8.23M | 0.01% |
+89,000
| New | +$6.86M |
|
150
CrowdStrike
CRWD
$218B
| $7.37M | 0.01% |
120,000
| – | – |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Alkeon Capital Management held 195 positions worth $59.2B, down 13% from $67.7B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Alkeon Capital Management withdrew a net $7.82B in Q3 2021, closing 19 positions and reducing 72 holdings. Its most notable exit was Pinterest, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Alkeon Capital Management opened a new position in Peloton Interactive worth $283M.
- Alkeon Capital Management's largest Q3 2021 buy was Peloton Interactive: 3,247,076 shares worth $283M.
- Alkeon Capital Management added most to UiPath in Q3 2021, an estimated $718M increase.
- Alkeon Capital Management's biggest Q3 2021 reduction was Apple, cutting an estimated $332M.
- Alkeon Capital Management fully exited Pinterest in Q3 2021, selling an estimated $357M.
- Alkeon Capital Management's ten largest holdings make up 53% of its $59.2B portfolio in Q3 2021.
- Alkeon Capital Management opened 15 new positions and closed 19 in Q3 2021.
- Alkeon Capital Management's portfolio value fell 13% quarter-over-quarter to $59.2B.
Based on Alkeon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.